Mostrar el registro sencillo del ítem
dc.contributor.author | Cachay Figueroa, Rodrigo Antonio | |
dc.contributor.author | Watanabe Tejada, Martín Takeshi | |
dc.contributor.author | Cuno Quiñones, Katiuska Delia | |
dc.contributor.author | Gil Zacarías, Marcela Dayana | |
dc.contributor.author | Coombes Perez, Carolina Soledad | |
dc.contributor.author | Ballena, Isabel | |
dc.contributor.author | Mejía Cordero, Fernando Alonso | |
dc.contributor.author | Medina Palomino, Félix Álvaro | |
dc.contributor.author | Gayoso Cervantes, Oscar Danilo | |
dc.contributor.author | Seas Ramos, Carlos Rafael | |
dc.contributor.author | Otero Vegas, Larissa | |
dc.contributor.author | Gotuzzo Herencia, José Eduardo | |
dc.coverage.spatial | Lima, Perú | |
dc.date.accessioned | 2023-05-19T14:08:33Z | |
dc.date.available | 2023-05-19T14:08:33Z | |
dc.date.issued | 2023 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12866/13519 | |
dc.description.abstract | INTRODUCTION: The sequelae of COVID-19 have been described as a multisystemic condition, with a great impact on the cardiovascular and pulmonary systems with abnormalities in pulmonary function tests, such as lower diffusing capacity of the lung for carbon monoxide (DLco) levels and pathological patterns in spirometry; persistence of radiological lesions; cardiac involvement such as myocarditis and pericarditis; and an increase in mental disorders such as anxiety and depression. Several factors, such as infection severity during the acute phase as well as vaccination status, have shown some variable effects on these post-COVID-19 conditions, mainly at a clinical level such as symptoms persistence. Longitudinal assessments and reversibility of changes across the spectrum of disease severity are required to understand the long-term impact of COVID-19. METHODS AND ANALYSIS: A prospective cohort study aims to assess the impact of SARS-CoV-2 infection on cardiopulmonary function and quality of life after the acute phase of the disease over a 6-month follow-up period. Sample size was calculated to recruit 200 participants with confirmatory COVID-19 tests who will be subsequently classified according to infection severity. Four follow-up visits at baseline, month 1, month 3 and month 6 after discharge from the acute phase of the infection will be scheduled as well as procedures such as spirometry, DLco test, 6-minute walk test, chest CT scan, echocardiogram, ECG, N-terminal pro-B-type natriuretic peptide measurement and RAND-36 scale. Primary outcomes are defined as abnormal pulmonary function test considered as DLco <80%, abnormal cardiovascular function considered as left ventricular ejection fraction <50% and abnormal quality of life considered as a <40 score for each sphere in the RAND-36-Item Short Form Health Survey. | en_US |
dc.language.iso | eng | |
dc.publisher | BMJ Group | |
dc.relation.ispartofseries | BMJ Open | |
dc.rights | info:eu-repo/semantics/restrictedAccess | |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es | |
dc.subject | cardiopulmonary | en_US |
dc.subject | quality of life | en_US |
dc.subject | patients | en_US |
dc.subject | SARS-CoV-2 infection | en_US |
dc.subject | Peru | en_US |
dc.subject.mesh | Enfermedades Cardiovasculares | |
dc.subject.mesh | Calidad de Vida | |
dc.subject.mesh | Pacientes | |
dc.subject.mesh | COVID-19 | |
dc.subject.mesh | Perú | |
dc.title | Long-term impact on cardiopulmonary function and quality of life among patients recovered from SARS-CoV-2 infection in a 6-month follow-up period in Lima, Peru: FUNCTION cohort study protocol. | en_US |
dc.type | info:eu-repo/semantics/article | |
dc.identifier.doi | https://doi.org/10.1136/bmjopen-2022-067365 | |
dc.subject.ocde | https://purl.org/pe-repo/ocde/ford#3.02.04 | |
dc.relation.issn | 2044-6055 |
Ficheros | Tamaño | Formato | Ver |
---|---|---|---|
No hay ficheros asociados a este ítem. |